| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $68.9M | +5.8% | +5.0% |
| Cost of Revenue | $10.4M | -1.9% | -6.2% |
| R&D Expense | $35.7M | +3.0% | +11.8% |
| SG&A Expense | $16.3M | +3.0% | -5.5% |
| Operating Income | -$17.2M | +15.0% | +17.1% |
| Pre-tax Income | -$12.7M | +15.7% | +13.6% |
| Income Tax | $131K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.1M | -9.6% | +12.9% |
| Accounts Receivable | $33.1M | +22.3% | +12.1% |
| Current Assets | $448.4M | +0.0% | -4.4% |
| Total Assets | $488.9M | -0.3% | -5.5% |
| Current Liabilities | $33.4M | +1.8% | +24.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | — |
| Capital Expenditures | $502K | — | — |
| Investing Cash Flow | $36.0M | — | — |
| Financing Cash Flow | -$25.2M | — | — |
| Free Cash Flow | -$3.5M | — | — |
| -51.1% |
| -22.0% |
| Net Income | -$12.9M | +16.3% | +13.7% |
| EPS (Basic) | -$0.03 | +25.0% | +25.0% |
| EPS (Diluted) | -$0.03 | +25.0% | +25.0% |
| $59.3M |
| -2.6% |
| -3.8% |
| Stockholders' Equity | $429.7M | +0.0% | -5.8% |